Stereotactic Surgery Devices Market Size, Share & Trends Analysis Report By Type (Gamma Knife, Linear Accelerator, CyberKnife, Proton Beam Therapy), By Region, And Segment Forecasts, 2018 - 2025
This report can be delivered to the clients within 72 Hours
The global stereotactic surgery devices market size is expected to reach USD 25.9 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.1% during the forecast period. Stereotactic surgery is a minimally invasive alternative for traditional invasive ablation and biopsy methods. Since, stereotactic surgery has various advantages such as higher efficacy, minimal or no surgical incisions, and lower risk of damage to healthy cells, it is replacing conventional radiotherapies. These surgical procedures have helped overcome drawbacks associated with traditional invasive surgeries, such as destruction of healthy cells and higher risk of recurrence & postoperative complications.
Only around 10.0% of the population in low and middle-income countries have access to radiation therapy, owing to dearth of radiation therapy devices. A market leader, Elekta, in its 2016 annual report stated that the number of installations of linear accelerators in high-income countries was approximately 13,000, whereas the requirement was around 25,000. Hence, huge demand-supply discrepancy of radiotherapy devices is likely to open new avenues for major market players in developing countries.
Further key findings from the study suggest:
The global stereotactic surgery devices market size is expected to reach USD 25.9 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.1% during the forecast period. Stereotactic surgery is a minimally invasive alternative for traditional invasive ablation and biopsy methods. Since, stereotactic surgery has various advantages such as higher efficacy, minimal or no surgical incisions, and lower risk of damage to healthy cells, it is replacing conventional radiotherapies. These surgical procedures have helped overcome drawbacks associated with traditional invasive surgeries, such as destruction of healthy cells and higher risk of recurrence & postoperative complications.
Only around 10.0% of the population in low and middle-income countries have access to radiation therapy, owing to dearth of radiation therapy devices. A market leader, Elekta, in its 2016 annual report stated that the number of installations of linear accelerators in high-income countries was approximately 13,000, whereas the requirement was around 25,000. Hence, huge demand-supply discrepancy of radiotherapy devices is likely to open new avenues for major market players in developing countries.
Further key findings from the study suggest:
- Linear accelerators (LINAC) accounted for the leading volume share in 2017, owing to higher affordability and larger commercial availability
- CyberKnife is poised to exhibit the fastest growth over the forecast period owing to their growing adoption in developing countries
- North America dominated the market in 2017 due to number of government initiatives focused on creating awareness regarding availability of advanced treatment options and presence of developed healthcare infrastructure
- Some of the major players operating in the market are Siemens Ag, Elekta AB, Varian Medical Systems, IBA, and Accuray Incorporated
- These players dominate the market with their strong brand identity and extensive geographical reach attained through various strategic initiatives such as mergers & acquisitions and partnership agreements.
CHAPTER 1 REPORT SCOPE
1.1 Market Segmentation and Scope
1.2 Regional Segmentation and Scope
CHAPTER 2 RESEARCH METHODOLOGY
2.1 Information procurement
2.2 Data Analysis
2.3 Approaches for market estimation
2.3.1 Approach 1: Demand Analysis & Bottom up Approach
2.3.2 Approach 2: Top down market estimation
2.3.3 Approach 3: Commodity flow and bottom up market estimation
2.3.4 Approach 4: KoL perspective based market sizing
CHAPTER 3 OBJECTIVE
CHAPTER 4 EXECUTIVE SUMMARY
4.1 Market Snapshot
CHAPTER 5 MARKET DEFINITIONS
5.1 Segment Definitions
5.1.1 Technology Type
5.1.1.1 Gamma Knife
5.1.1.2 Linear Accelerator
5.1.1.3 Particle Beam
5.1.1.4 CyberKnife
CHAPTER 6 INDUSTRY OUTLOOK
6.1 Business Segment Trends
6.1.1 Technology business analysis
6.1.2 Regional business analysis
6.2 Market Variable Analysis
6.2.1 Market Driver Analysis
6.2.2 Market Restraint Analysis
6.3 Business Environment Analysis Tools
6.3.1 Penetration & growth prospect mapping
6.3.2 Stereotactic Surgery Devices Market - SWOT Analysis, By Factor (political & legal, economic and technological)
6.3.3 Stereotactic Surgery Devices: Industry Analysis - Porter’s
6.3.4 Value Chain Analysis
CHAPTER 7 STEREOTACTIC SURGERY DEVICES MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
7.1 Stereotactic Surgery Devices Market Product Type Outlook Key Takeaways
7.2 Stereotactic Surgery Devices Market: Product Type Movement Analysis
7.3 Gamma Knife
7.3.1 Gamma knife market, 2014 - 2025 (USD Million)
7.4 Linear Accelerators (LINAC)
7.4.1 LINAC market, 2014 - 2025 (USD Million)
7.5 Proton Beam Therapy
7.5.1 Proton beam therapy market, 2014 - 2025 (USD Million)
7.6 CyberKnife
7.6.1 Cyberknife market, 2014 - 2025 (USD Million)
CHAPTER 8 STEREOTACTIC SURGERY DEVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY PRODUCT TYPE
8.1 Stereotactic Surgery Devices Market: Regional Movement Analysis
8.2 North America
8.2.1 Installed base of stereotactic surgery devices : By Product Type (% per device type, 2016)
8.2.2 North America market, 2014 - 2025 (USD Million)
8.2.3 U.S.
8.2.3.1 U.S. market, 2014 - 2025 (USD Million)
8.2.4 Canada
8.2.4.1 Canada market, 2014 - 2025 (USD Million)
8.3 Europe
8.3.1 Installed base of stereotactic surgery devices : By Product Type (% per device type, 2016)
8.3.2 Europe market, 2014 - 2025 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. market, 2014 - 2025 (USD Million)
8.3.4 Germany
8.3.4.1 Germany market, 2014 - 2025 (USD Million)
8.3.5 Greece
8.3.5.1 Greece market, 2014 - 2025 (USD Million)
8.3.6 Italy
8.3.6.1 Italy market, 2014 - 2025 (USD Million)
8.3.7 Spain
8.3.7.1 Spain market, 2014 - 2025 (USD Million)
8.3.8 France
8.3.8.1 France market, 2014 - 2025 (USD Million)
8.3.9 Belgium
8.3.9.1 Belgium market, 2014 - 2025 (USD Million)
8.3.10 Sweden
8.3.10.1 Sweden market, 2014 - 2025 (USD Million)
8.4 Asia Pacific
8.4.1 Installed base of stereotactic surgery devices: By Product Type (% per device type, 2016)
8.5 Asia Pacific market, 2014 - 2025 (USD Million)
8.5.1 Japan
8.5.1.1 Japan market, 2014 - 2025 (USD Million)
8.5.2 China
8.5.2.1 China market, 2014 - 2025 (USD Million)
8.5.3 India
8.5.3.1 India market, 2014 - 2025 (USD Million)
8.5.4 Australia
8.5.4.1 Australia market, 2014 - 2025 (USD Million)
8.5.5 Singapore
8.5.5.1 Singapore market, 2014 - 2025 (USD Million)
8.5.6 South Korea
8.5.6.1 South Korea market, 2014 - 2025 (USD Million)
8.5.7 Malaysia
8.5.7.1 Malaysia market, 2014 - 2025 (USD Million)
8.5.8 New Zealand
8.5.8.1 New Zealand market, 2014 - 2025 (USD Million)
8.5.9 Indonesia
8.5.9.1 Indonesia market, 2014 - 2025 (USD Million)
8.5.10 Hong Kong
8.5.10.1 Hong Kong market, 2014 - 2025 (USD Million)
8.6 Latin America
8.7 Latin America market, 2014 - 2025 (USD Million)
8.7.1 Brazil
8.7.1.1 Brazil market, 2014 - 2025 (USD Million)
8.7.2 Mexico
8.7.2.1 Mexico market, 2014 - 2025 (USD Million)
8.7.3 Argentina
8.7.3.1 Argentina market, 2014 - 2025 (USD Million)
8.8 Middle East and Africa (MEA)
8.9 MEA market, 2014 - 2025 (USD Million)
8.9.1 Africa
8.9.1.1 Africa market, 2014 - 2025 (USD Million)
8.9.2 Morocco
8.9.2.1 Morocco market, 2014 - 2025 (USD Million)
8.9.3 Kuwait
8.9.3.1 Kuwait market, 2014 - 2025 (USD Million)
8.9.4 Iran
8.9.4.1 Iran market, 2014 - 2025 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Strategy framework
9.2 Company Profiles
9.2.1 AstraZeneca
9.2.1.1 Company Overview
9.2.1.2 Financial performance
9.2.1.3 Product Benchmarking
9.2.1.4 Strategic Initiatives
9.2.2 Bayer AG
9.2.2.1 Company Overview
9.2.2.2 Financial Performance
9.2.2.3 Product Benchmarking
9.2.2.4 Strategic Initiatives
9.2.3 Merck KGaA
9.2.3.1 Company Overview
9.2.3.2 Financial Performance
9.2.3.3 Product Benchmarking
9.2.3.4 Strategic Initiatives
9.2.4 Abbott
9.2.4.1 Company Overview
9.2.4.2 Financial performance
9.2.4.3 Product Benchmarking
9.2.4.4 Strategic Initiatives
9.2.5 Pfizer, Inc.
9.2.5.1 Company Overview
9.2.5.2 Financial Performance
9.2.5.3 Product Benchmarking
9.2.5.4 Strategic Initiatives
9.2.6 Sanofi
9.2.6.1 Company Overview
9.2.6.2 Financial Performance
9.2.6.3 Product Benchmarking
9.2.6.4 Strategic Initiatives
9.2.7 Bristol Myers Squibb Company
9.2.7.1 Company Overview
9.2.7.2 Financial Performance
9.2.7.3 Product Benchmarking
9.2.7.4 Strategic Initiatives
9.2.8 Teva Pharmaceutical Industries Ltd.
9.2.8.1 Company Overview
9.2.8.2 Financial Performance
9.2.8.3 Product Benchmarking
9.2.8.4 Strategic Initiatives
9.2.9 Novartis AG
9.2.9.1 Company Overview
9.2.9.2 Financial Performance
9.2.9.3 Product Benchmarking
9.2.9.4 Strategic Initiatives
9.2.10 Ferring B.V.
9.2.10.1 Company Overview
9.2.10.2 Financial Performance
9.2.10.3 Product Benchmarking
9.2.10.4 Strategic Initiatives
1.1 Market Segmentation and Scope
1.2 Regional Segmentation and Scope
CHAPTER 2 RESEARCH METHODOLOGY
2.1 Information procurement
2.2 Data Analysis
2.3 Approaches for market estimation
2.3.1 Approach 1: Demand Analysis & Bottom up Approach
2.3.2 Approach 2: Top down market estimation
2.3.3 Approach 3: Commodity flow and bottom up market estimation
2.3.4 Approach 4: KoL perspective based market sizing
CHAPTER 3 OBJECTIVE
CHAPTER 4 EXECUTIVE SUMMARY
4.1 Market Snapshot
CHAPTER 5 MARKET DEFINITIONS
5.1 Segment Definitions
5.1.1 Technology Type
5.1.1.1 Gamma Knife
5.1.1.2 Linear Accelerator
5.1.1.3 Particle Beam
5.1.1.4 CyberKnife
CHAPTER 6 INDUSTRY OUTLOOK
6.1 Business Segment Trends
6.1.1 Technology business analysis
6.1.2 Regional business analysis
6.2 Market Variable Analysis
6.2.1 Market Driver Analysis
6.2.2 Market Restraint Analysis
6.3 Business Environment Analysis Tools
6.3.1 Penetration & growth prospect mapping
6.3.2 Stereotactic Surgery Devices Market - SWOT Analysis, By Factor (political & legal, economic and technological)
6.3.3 Stereotactic Surgery Devices: Industry Analysis - Porter’s
6.3.4 Value Chain Analysis
CHAPTER 7 STEREOTACTIC SURGERY DEVICES MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
7.1 Stereotactic Surgery Devices Market Product Type Outlook Key Takeaways
7.2 Stereotactic Surgery Devices Market: Product Type Movement Analysis
7.3 Gamma Knife
7.3.1 Gamma knife market, 2014 - 2025 (USD Million)
7.4 Linear Accelerators (LINAC)
7.4.1 LINAC market, 2014 - 2025 (USD Million)
7.5 Proton Beam Therapy
7.5.1 Proton beam therapy market, 2014 - 2025 (USD Million)
7.6 CyberKnife
7.6.1 Cyberknife market, 2014 - 2025 (USD Million)
CHAPTER 8 STEREOTACTIC SURGERY DEVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY PRODUCT TYPE
8.1 Stereotactic Surgery Devices Market: Regional Movement Analysis
8.2 North America
8.2.1 Installed base of stereotactic surgery devices : By Product Type (% per device type, 2016)
8.2.2 North America market, 2014 - 2025 (USD Million)
8.2.3 U.S.
8.2.3.1 U.S. market, 2014 - 2025 (USD Million)
8.2.4 Canada
8.2.4.1 Canada market, 2014 - 2025 (USD Million)
8.3 Europe
8.3.1 Installed base of stereotactic surgery devices : By Product Type (% per device type, 2016)
8.3.2 Europe market, 2014 - 2025 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. market, 2014 - 2025 (USD Million)
8.3.4 Germany
8.3.4.1 Germany market, 2014 - 2025 (USD Million)
8.3.5 Greece
8.3.5.1 Greece market, 2014 - 2025 (USD Million)
8.3.6 Italy
8.3.6.1 Italy market, 2014 - 2025 (USD Million)
8.3.7 Spain
8.3.7.1 Spain market, 2014 - 2025 (USD Million)
8.3.8 France
8.3.8.1 France market, 2014 - 2025 (USD Million)
8.3.9 Belgium
8.3.9.1 Belgium market, 2014 - 2025 (USD Million)
8.3.10 Sweden
8.3.10.1 Sweden market, 2014 - 2025 (USD Million)
8.4 Asia Pacific
8.4.1 Installed base of stereotactic surgery devices: By Product Type (% per device type, 2016)
8.5 Asia Pacific market, 2014 - 2025 (USD Million)
8.5.1 Japan
8.5.1.1 Japan market, 2014 - 2025 (USD Million)
8.5.2 China
8.5.2.1 China market, 2014 - 2025 (USD Million)
8.5.3 India
8.5.3.1 India market, 2014 - 2025 (USD Million)
8.5.4 Australia
8.5.4.1 Australia market, 2014 - 2025 (USD Million)
8.5.5 Singapore
8.5.5.1 Singapore market, 2014 - 2025 (USD Million)
8.5.6 South Korea
8.5.6.1 South Korea market, 2014 - 2025 (USD Million)
8.5.7 Malaysia
8.5.7.1 Malaysia market, 2014 - 2025 (USD Million)
8.5.8 New Zealand
8.5.8.1 New Zealand market, 2014 - 2025 (USD Million)
8.5.9 Indonesia
8.5.9.1 Indonesia market, 2014 - 2025 (USD Million)
8.5.10 Hong Kong
8.5.10.1 Hong Kong market, 2014 - 2025 (USD Million)
8.6 Latin America
8.7 Latin America market, 2014 - 2025 (USD Million)
8.7.1 Brazil
8.7.1.1 Brazil market, 2014 - 2025 (USD Million)
8.7.2 Mexico
8.7.2.1 Mexico market, 2014 - 2025 (USD Million)
8.7.3 Argentina
8.7.3.1 Argentina market, 2014 - 2025 (USD Million)
8.8 Middle East and Africa (MEA)
8.9 MEA market, 2014 - 2025 (USD Million)
8.9.1 Africa
8.9.1.1 Africa market, 2014 - 2025 (USD Million)
8.9.2 Morocco
8.9.2.1 Morocco market, 2014 - 2025 (USD Million)
8.9.3 Kuwait
8.9.3.1 Kuwait market, 2014 - 2025 (USD Million)
8.9.4 Iran
8.9.4.1 Iran market, 2014 - 2025 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Strategy framework
9.2 Company Profiles
9.2.1 AstraZeneca
9.2.1.1 Company Overview
9.2.1.2 Financial performance
9.2.1.3 Product Benchmarking
9.2.1.4 Strategic Initiatives
9.2.2 Bayer AG
9.2.2.1 Company Overview
9.2.2.2 Financial Performance
9.2.2.3 Product Benchmarking
9.2.2.4 Strategic Initiatives
9.2.3 Merck KGaA
9.2.3.1 Company Overview
9.2.3.2 Financial Performance
9.2.3.3 Product Benchmarking
9.2.3.4 Strategic Initiatives
9.2.4 Abbott
9.2.4.1 Company Overview
9.2.4.2 Financial performance
9.2.4.3 Product Benchmarking
9.2.4.4 Strategic Initiatives
9.2.5 Pfizer, Inc.
9.2.5.1 Company Overview
9.2.5.2 Financial Performance
9.2.5.3 Product Benchmarking
9.2.5.4 Strategic Initiatives
9.2.6 Sanofi
9.2.6.1 Company Overview
9.2.6.2 Financial Performance
9.2.6.3 Product Benchmarking
9.2.6.4 Strategic Initiatives
9.2.7 Bristol Myers Squibb Company
9.2.7.1 Company Overview
9.2.7.2 Financial Performance
9.2.7.3 Product Benchmarking
9.2.7.4 Strategic Initiatives
9.2.8 Teva Pharmaceutical Industries Ltd.
9.2.8.1 Company Overview
9.2.8.2 Financial Performance
9.2.8.3 Product Benchmarking
9.2.8.4 Strategic Initiatives
9.2.9 Novartis AG
9.2.9.1 Company Overview
9.2.9.2 Financial Performance
9.2.9.3 Product Benchmarking
9.2.9.4 Strategic Initiatives
9.2.10 Ferring B.V.
9.2.10.1 Company Overview
9.2.10.2 Financial Performance
9.2.10.3 Product Benchmarking
9.2.10.4 Strategic Initiatives
LIST OF TABLES
Table 1 North America stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 2 U.S stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 3 Canada stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 4 Europe stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 5 U.K. stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 6 Germany stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 7 Greece stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 8 Italy stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 9 Spain stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 10 France stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 11 Belgium stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 12 Sweden stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 13 Asia Pacific stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 14 Japan stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 15 India stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 16 China stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 17 Australia stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 18 Singapore stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 19 South Korea stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 20 Malaysia stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 21 New Zealand stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 22 Indonesia stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 23 Hong Kong stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 24 Latin America stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 25 Brazil stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 26 Mexico stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 27 Argentina stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 28 MEA stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 29 Morocco stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 30 Kuwait stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 31 Iran stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 32 South Africa stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 1 North America stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 2 U.S stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 3 Canada stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 4 Europe stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 5 U.K. stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 6 Germany stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 7 Greece stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 8 Italy stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 9 Spain stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 10 France stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 11 Belgium stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 12 Sweden stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 13 Asia Pacific stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 14 Japan stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 15 India stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 16 China stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 17 Australia stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 18 Singapore stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 19 South Korea stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 20 Malaysia stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 21 New Zealand stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 22 Indonesia stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 23 Hong Kong stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 24 Latin America stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 25 Brazil stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 26 Mexico stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 27 Argentina stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 28 MEA stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 29 Morocco stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 30 Kuwait stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 31 Iran stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
Table 32 South Africa stereotactic surgery devices market revenue, by Product Type, 2014 - 2025 (USD Million)
LIST OF FIGURES
Fig. 1 Stereotactic Surgery Devices Market Snapshot
Fig. 2 Market trends & outlook
Fig. 3 Stereotactic Surgery Devices Market segmentation & scope
Fig. 4 Stereotactic Surgery Devices Market Driver Impact
Fig. 5 Stereotactic Surgery Devices Market Restraint Impact
Fig. 6 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 7 Porter’s Five Forces Analysis
Fig. 8 Value Chain Analysis
Fig. 9 Stereotactic Surgery Devices market: type outlook key takeaways
Fig. 10 Stereotactic surgery devices market: type movement analysis
Fig. 11 Gamma Knife market estimates and forecast, 2014 - 2025
Fig. 12 Linear Accelerators (LINAC) market estimates and forecast, 2014 - 2025
Fig. 13 Proton Beam radiotherapy market estimates and forecast, 2014 - 2025
Fig. 14 Cyberknife market estimates and forecast, 2014 - 2025
Fig. 15 Stereotactic surgery devices regional outlook and key takeaways
Fig. 16 North America
Fig. 17 Installed base of stereotactic surgery devices by product type (% per device type, 2016)
Fig. 18 North America market estimates and forecast, 2014 - 2025
Fig. 19 North America volume estimates and forecast 2014 - 2025 (‘000)
Fig. 20 U.S. market estimates and forecast 2014 - 2025
Fig. 21 U.S. volume estimates and forecast 2014 - 2025 (‘000)
Fig. 22 Canada market estimates and forecast 2014 - 2025
Fig. 23 Canada volume estimates and forecast 2014 - 2025 (‘000)
Fig. 24 Europe
Fig. 25 Installed base of stereotactic surgery devices by technology (% per device type, 2016)
Fig. 26 Europe market estimates and forecast, 2014 - 2025
Fig. 27 Europe volume estimates and forecast 2014 - 2025 (‘000)
Fig. 28 U.K. market estimates and forecast, 2014 - 2025
Fig. 29 U.K. volume estimates and forecast 2014 - 2025 (‘000)
Fig. 30 Germany market estimates and forecast, 2014 - 2025
Fig. 31 Germany volume estimates and forecast 2014 - 2025 (‘000)
Fig. 32 Greece market estimates and forecast, 2014 - 2025
Fig. 33 Greece volume estimates and forecast 2014 - 2025 (‘000)
Fig. 34 Italy market estimates and forecast, 2014 - 2025
Fig. 35 Italy volume estimates and forecast 2014 - 2025 (‘000)
Fig. 36 Spain market estimates and forecast, 2014 - 2025
Fig. 37 Spain volume estimates and forecast 2014 - 2025 (‘000)
Fig. 38 France market estimates and forecast, 2014 - 2025
Fig. 39 France volume estimates and forecast 2014 - 2025 (‘000)
Fig. 40 Belgium market estimates and forecast, 2014 - 2025
Fig. 41 Belgium volume estimates and forecast 2014 - 2025 (‘000)
Fig. 42 Sweden market estimates and forecast, 2014 - 2025
Fig. 43 Sweden volume estimates and forecast 2014 - 2025 (‘000)
Fig. 44 Asia-Pacific
Fig. 45 Asia-Pacific market estimates and forecast, 2014 - 2025
Fig. 46 Asia-Pacific volume estimates and forecast 2014 - 2025 (‘000)
Fig. 47 Japan market estimates and forecast, 2014 - 2025
Fig. 48 Japan volume estimates and forecast 2014 - 2025 (‘000)
Fig. 49 India market estimates and forecast, 2014 - 2025
Fig. 50 India volume estimates and forecast 2014 - 2025 (‘000)
Fig. 51 China market estimates and forecast, 2014 - 2025
Fig. 52 China volume estimates and forecast 2014 - 2025 (‘000)
Fig. 53 Australia market estimates and forecast, 2014 - 2025
Fig. 54 Australia volume estimates and forecast 2014 - 2025 (‘000)
Fig. 55 Singapore market estimates and forecast, 2014 - 2025
Fig. 56 Singapore volume estimates and forecast 2014 - 2025 (‘000)
Fig. 57 South Korea market estimates and forecast, 2014 - 2025
Fig. 58 South Korea volume estimates and forecast 2014 - 2025 (‘000)
Fig. 59 Malaysia market estimates and forecast, 2014 - 2025
Fig. 60 Malaysia volume estimates and forecast 2014 - 2025 (‘000)
Fig. 61 New Zealand market estimates and forecast, 2014 - 2025
Fig. 62 New Zealand volume estimates and forecast 2014 - 2025 (‘000)
Fig. 63 Indonesia market estimates and forecast, 2014 - 2025
Fig. 64 Indonesia volume estimates and forecast 2014 - 2025 (‘000)
Fig. 65 Hong Kong market estimates and forecast, 2014 - 2025
Fig. 66 Hong Kong volume estimates and forecast 2014 - 2025 (‘000)
Fig. 67 Latin America
Fig. 68 Latin America market estimates and forecast, 2014 - 2025
Fig. 69 Latin America volume estimates and forecast, 2014 - 2025 (‘000)
Fig. 70 Brazil market estimates and forecast, 2014 - 2025
Fig. 71 Brazil volume estimates and forecast 2014 - 2025 (‘000)
Fig. 72 Mexico market estimates and forecast, 2014 - 2025
Fig. 73 Mexico volume estimates and forecast 2014 - 2025 (‘000)
Fig. 74 Argentina market estimates and forecast, 2014 - 2025
Fig. 75 Argentina volume estimates and forecast 2014 - 2025 (‘000)
Fig. 76 Middle East & Africa
Fig. 77 Middle East & Africa market estimates and forecast, 2014 - 2025
Fig. 78 Middle East & Africa volume estimates and forecast 2014 - 2025 (‘000)
Fig. 79 Morrocco market estimates and forecast, 2014 - 2025
Fig. 80 Morrocco volume estimates and forecast 2014 - 2025 (‘000)
Fig. 81 Kuwait market estimates and forecast, 2014 - 2025
Fig. 82 Kuwait volume estimates and forecast 2014 - 2025 (‘000)
Fig. 83 Iran market estimates and forecast, 2014 - 2025
Fig. 84 Iran volume estimates and forecast 2014 - 2025 (‘000)
Fig. 85 South Africa market estimates and forecast, 2014 - 2025
Fig. 86 South Africa volume estimates and forecast 2014 - 2025 (‘000)
Fig. 87 Company Profile
Fig. 1 Stereotactic Surgery Devices Market Snapshot
Fig. 2 Market trends & outlook
Fig. 3 Stereotactic Surgery Devices Market segmentation & scope
Fig. 4 Stereotactic Surgery Devices Market Driver Impact
Fig. 5 Stereotactic Surgery Devices Market Restraint Impact
Fig. 6 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 7 Porter’s Five Forces Analysis
Fig. 8 Value Chain Analysis
Fig. 9 Stereotactic Surgery Devices market: type outlook key takeaways
Fig. 10 Stereotactic surgery devices market: type movement analysis
Fig. 11 Gamma Knife market estimates and forecast, 2014 - 2025
Fig. 12 Linear Accelerators (LINAC) market estimates and forecast, 2014 - 2025
Fig. 13 Proton Beam radiotherapy market estimates and forecast, 2014 - 2025
Fig. 14 Cyberknife market estimates and forecast, 2014 - 2025
Fig. 15 Stereotactic surgery devices regional outlook and key takeaways
Fig. 16 North America
Fig. 17 Installed base of stereotactic surgery devices by product type (% per device type, 2016)
Fig. 18 North America market estimates and forecast, 2014 - 2025
Fig. 19 North America volume estimates and forecast 2014 - 2025 (‘000)
Fig. 20 U.S. market estimates and forecast 2014 - 2025
Fig. 21 U.S. volume estimates and forecast 2014 - 2025 (‘000)
Fig. 22 Canada market estimates and forecast 2014 - 2025
Fig. 23 Canada volume estimates and forecast 2014 - 2025 (‘000)
Fig. 24 Europe
Fig. 25 Installed base of stereotactic surgery devices by technology (% per device type, 2016)
Fig. 26 Europe market estimates and forecast, 2014 - 2025
Fig. 27 Europe volume estimates and forecast 2014 - 2025 (‘000)
Fig. 28 U.K. market estimates and forecast, 2014 - 2025
Fig. 29 U.K. volume estimates and forecast 2014 - 2025 (‘000)
Fig. 30 Germany market estimates and forecast, 2014 - 2025
Fig. 31 Germany volume estimates and forecast 2014 - 2025 (‘000)
Fig. 32 Greece market estimates and forecast, 2014 - 2025
Fig. 33 Greece volume estimates and forecast 2014 - 2025 (‘000)
Fig. 34 Italy market estimates and forecast, 2014 - 2025
Fig. 35 Italy volume estimates and forecast 2014 - 2025 (‘000)
Fig. 36 Spain market estimates and forecast, 2014 - 2025
Fig. 37 Spain volume estimates and forecast 2014 - 2025 (‘000)
Fig. 38 France market estimates and forecast, 2014 - 2025
Fig. 39 France volume estimates and forecast 2014 - 2025 (‘000)
Fig. 40 Belgium market estimates and forecast, 2014 - 2025
Fig. 41 Belgium volume estimates and forecast 2014 - 2025 (‘000)
Fig. 42 Sweden market estimates and forecast, 2014 - 2025
Fig. 43 Sweden volume estimates and forecast 2014 - 2025 (‘000)
Fig. 44 Asia-Pacific
Fig. 45 Asia-Pacific market estimates and forecast, 2014 - 2025
Fig. 46 Asia-Pacific volume estimates and forecast 2014 - 2025 (‘000)
Fig. 47 Japan market estimates and forecast, 2014 - 2025
Fig. 48 Japan volume estimates and forecast 2014 - 2025 (‘000)
Fig. 49 India market estimates and forecast, 2014 - 2025
Fig. 50 India volume estimates and forecast 2014 - 2025 (‘000)
Fig. 51 China market estimates and forecast, 2014 - 2025
Fig. 52 China volume estimates and forecast 2014 - 2025 (‘000)
Fig. 53 Australia market estimates and forecast, 2014 - 2025
Fig. 54 Australia volume estimates and forecast 2014 - 2025 (‘000)
Fig. 55 Singapore market estimates and forecast, 2014 - 2025
Fig. 56 Singapore volume estimates and forecast 2014 - 2025 (‘000)
Fig. 57 South Korea market estimates and forecast, 2014 - 2025
Fig. 58 South Korea volume estimates and forecast 2014 - 2025 (‘000)
Fig. 59 Malaysia market estimates and forecast, 2014 - 2025
Fig. 60 Malaysia volume estimates and forecast 2014 - 2025 (‘000)
Fig. 61 New Zealand market estimates and forecast, 2014 - 2025
Fig. 62 New Zealand volume estimates and forecast 2014 - 2025 (‘000)
Fig. 63 Indonesia market estimates and forecast, 2014 - 2025
Fig. 64 Indonesia volume estimates and forecast 2014 - 2025 (‘000)
Fig. 65 Hong Kong market estimates and forecast, 2014 - 2025
Fig. 66 Hong Kong volume estimates and forecast 2014 - 2025 (‘000)
Fig. 67 Latin America
Fig. 68 Latin America market estimates and forecast, 2014 - 2025
Fig. 69 Latin America volume estimates and forecast, 2014 - 2025 (‘000)
Fig. 70 Brazil market estimates and forecast, 2014 - 2025
Fig. 71 Brazil volume estimates and forecast 2014 - 2025 (‘000)
Fig. 72 Mexico market estimates and forecast, 2014 - 2025
Fig. 73 Mexico volume estimates and forecast 2014 - 2025 (‘000)
Fig. 74 Argentina market estimates and forecast, 2014 - 2025
Fig. 75 Argentina volume estimates and forecast 2014 - 2025 (‘000)
Fig. 76 Middle East & Africa
Fig. 77 Middle East & Africa market estimates and forecast, 2014 - 2025
Fig. 78 Middle East & Africa volume estimates and forecast 2014 - 2025 (‘000)
Fig. 79 Morrocco market estimates and forecast, 2014 - 2025
Fig. 80 Morrocco volume estimates and forecast 2014 - 2025 (‘000)
Fig. 81 Kuwait market estimates and forecast, 2014 - 2025
Fig. 82 Kuwait volume estimates and forecast 2014 - 2025 (‘000)
Fig. 83 Iran market estimates and forecast, 2014 - 2025
Fig. 84 Iran volume estimates and forecast 2014 - 2025 (‘000)
Fig. 85 South Africa market estimates and forecast, 2014 - 2025
Fig. 86 South Africa volume estimates and forecast 2014 - 2025 (‘000)
Fig. 87 Company Profile
